Epipole, a Rosyth-based start-up which is developing a mass market monitoring and screening platform that can identify eye diseases that cause long-term damage and blindness, has been awarded Scottish EDGE’s largest prize to date of £150,000.

Epipole was founded in 2011 and has developed intellectual property in a range of medical imaging areas. The company has so far brought one product from the drawing board to market: a portable, low-cost tool called epiCam which is designed for clinicians to use in either tele-medicine applications in the field or the clinic.

The award to Epipole was part of £1.245 million awarded to Scotland’s most promising start-ups by the Scottish EDGE Fund on Monday evening. This week’s biannual awards bring to over £5m the amount that the fund has given in grants and loans to start-ups since the first awards in 2013.